mitomycin has been researched along with leupeptins in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banks, L; Mantovani, F | 1 |
| Ajay, AK; Bhat, MK; Chaube, B; Malvi, P; Meena, AS; Mohammad, N; Singh, SV | 1 |
2 other study(ies) available for mitomycin and leupeptins
| Article | Year |
|---|---|
Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
Topics: Acetylcysteine; Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma; Cell Nucleus; Cysteine Proteinase Inhibitors; DNA Damage; DNA-Binding Proteins; Female; Fibrosarcoma; Humans; Leupeptins; Mitomycin; Oncogene Proteins, Viral; Papillomaviridae; Polymorphism, Genetic; Repressor Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 1999 |
Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment.
Topics: Animals; Bystander Effect; Cell Proliferation; Fas Ligand Protein; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; In Situ Nick-End Labeling; Leupeptins; Macrophages; Mice, Inbred NOD; Mice, SCID; Mitomycin; PPAR gamma; Tumor Microenvironment; Uterine Cervical Neoplasms | 2015 |